Tibor Hlavaty
Overview
Explore the profile of Tibor Hlavaty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1028
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sturdik I, Hlavaty T, Payer J
Vnitr Lek
. 2016 May;
62(2):147-51.
PMID: 27172442
Fecal microbiota transplantation (FMT) is a therapeutic method, in which the fecal microflora from healthy donors is transmitted to the patient to restore the healthy microbial composition of the gut....
12.
Kollerova J, Koller T, Hlavaty T, Payer J
Vnitr Lek
. 2016 Apr;
61(12 Suppl 5):5S35-9.
PMID: 27124970
Inflammatory bowel disease is often accompanied by extraintestinal manifestations due to a common autoimmune etiopathogenesis, chronic systemic inflammation, frequent nutrition deficits, and the treatment. Endocrine system changes belong to manifestations...
13.
Kollerova J, Koller T, Hlavaty T, Payer J
Vnitr Lek
. 2016 Jan;
61 Suppl 5:35-9.
PMID: 26800471
Unlabelled: Inflammatory bowel disease is often accompanied by extraintestinal manifestations due to a common autoimmune etiopathogenesis, chronic systemic inflammation, frequent nutrition deficits, and the treatment. Endocrine system changes belong to...
14.
Hlavaty T, Krajcovicova A, Payer J
J Crohns Colitis
. 2015 Jun;
9(2):198-209.
PMID: 26046136
Background: The north–south geographical gradient of inflammatory bowel disease (IBD) prevalence, its epidemiology, the genetic association of vitamin D receptor polymorphisms, and results in animal models suggest that vitamin D...
15.
Rencz F, Pentek M, Bortlik M, Zagorowicz E, Hlavaty T, Sliwczynski A, et al.
World J Gastroenterol
. 2015 Feb;
21(6):1728-37.
PMID: 25684937
Biological drugs opened up new horizons in the management of inflammatory bowel diseases (IBD). This study focuses on access to biological therapy in IBD patients across 9 selected Central and...
16.
Hlavaty T, Krajcovicova A, Koller T, Toth J, Nevidanska M, Huorka M, et al.
World J Gastroenterol
. 2014 Nov;
20(42):15787-96.
PMID: 25400464
Aim: To investigate the effect of vitamin D (VD) concentrations and VD supplementation on health related quality of life in inflammatory bowel disease (IBD) patients. Methods: A cohort of 220...
17.
Krajcovicova A, Hlavaty T, Killinger Z, Miznerova E, Toth J, Letkovsky J, et al.
J Crohns Colitis
. 2014 Sep;
8(12):1693-701.
PMID: 25175812
Objective: There is a high prevalence of low bone mineral density (BMD) among patients with inflammatory bowel disease (IBD) although there is a lack of clinical data on the impact...
18.
Hlavaty T, Toth J, Koller T, Krajcovicova A, Oravcova S, Zelinkova Z, et al.
United European Gastroenterol J
. 2014 Jun;
1(2):109-19.
PMID: 24917948
Background: The aetiology of inflammatory bowel disease (IBD) is not known but is likely to involve a combination of genetic predisposition and environmental risk factors. Smoking has been associated consistently...
19.
Hlavaty T, Letkovsky J
Eur J Gastroenterol Hepatol
. 2014 Apr;
26(6):581-7.
PMID: 24722561
A biosimilar is a copy of an approved biological medicine whose patent protections have expired. Biosimilars of antibodies to tumour necrosis factor α (TNFα) are becoming important in the treatment...
20.
Krajcovicova A, Hlavaty T, Zelinkova Z, Letkovsky J, Huorka M
Eur J Gastroenterol Hepatol
. 2014 Feb;
26(4):485-7.
PMID: 24509644
We report here an unusual case of delayed hypersensitivity reaction in a young woman with ulcerative colitis after the first administration of infliximab (IFX). The patient developed severe serum-sickness-like reaction,...